Crystal and molecular structure of Perindopril erbumine (cas 107133-36-8) salt
-
Add time:08/11/2019 Source:sciencedirect.com
The crystal structure of perindopril (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid) erbumine salt C23H43N3O5, angiotensin-converting enzyme inhibitor, was determined from single-crystal X-ray diffraction data. The compound crystallizes in the triclinic, non-centrosymetric space group P1, with unit cell dimensions a = 6.575(3), b = 12.165(5), c = 16.988(8) Å and α = 97.153(4), β = 94.417(4), γ = 90.349(4)°, Z = 2. The structure was refined by full matrix least squares methods to R = 0.037. In the solid state ionized molecules of perindopril and erbumine are linked together forming a complex via O⋯HN+ hydrogen bonds between the positively charged amino groups of the erbuminium cations and oxygen atoms of the perindopril carboxylate groups. Intermolecular NH⋯O and CH⋯O contacts seem to be effective in the stabilization of the structure, resulting in the formation of a three-dimensional network.The gas-phase structure of perindopril–erbumine complex was optimized by the HF/6-31G(d) and Becke3LYP/6-31G(d) methods. The conformational behavior of this salt in water was examined using the CPCM and Onsager models. In both the gas phase and water solution the Perindopril erbumine (cas 107133-36-8) will exist in prevailing triclinic form.
We also recommend Trading Suppliers and Manufacturers of Perindopril erbumine (cas 107133-36-8). Pls Click Website Link as below: cas 107133-36-8 suppliers
Prev:Kinetic spectrophotometric method for the determination of Perindopril erbumine (cas 107133-36-8) in pure and commercial dosage forms
Next:Molecular structure and stability of Perindopril erbumine (cas 107133-36-8) and perindopril l) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Conventional univariate versus multivariate spectrophotometric assisted techniques for simultaneous determination of perindopril arginin and amlodipine besylate in presence of their degradation products08/19/2019
- Rationale for a single-pill combination of perindopril arginine and amlodipine besylate08/18/2019
- Safety profile of perindopril08/17/2019
- Molecular structure of antihypertensive drug perindopril, its active metabolite perindoprilat and impurity F08/16/2019
- Effects of perindopril on cardiovascular remodeling08/15/2019
- The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril erbumine (cas 107133-36-8) in aqueous solutions08/14/2019
- Efficacy and safety of perindopril arginine + amlodipine in hypertension08/13/2019
- Molecular structure and stability of Perindopril erbumine (cas 107133-36-8) and perindopril l08/12/2019
- Kinetic spectrophotometric method for the determination of Perindopril erbumine (cas 107133-36-8) in pure and commercial dosage forms08/10/2019


